E. Jähnchen

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

Prophylactic Oral Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair

Pharmacology and Management of the Vitamin K Antagonists

The Pharmacology of a New Nitric Oxide Donor: B-NOD

Oral Anticoagulation Treatment in the Elderly

Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery

Preoperative Amiodarone as Prophylaxis against Atrial Fibrillation after Heart Surgery

γ-Adrenergic Blockade Accelerates Conversion of Postoperative Supraventricular Tachyarrhythmias 

Structural Basis of the Drug-binding Specificity of Human Serum Albumin

Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy

Oral Anticoagulant Therapy

Glioblastoma and Other Malignant Gliomas

Antithrombotic Therapy for VTE Disease

Exercise Standards for Testing and Training

Drug-Induced Hepatotoxicity

Pharmacological Management of Atrial Fibrillation following Cardiac Surgery

Emergency Hospitalizations for Adverse Drug Events in Older Americans

Enantioselective Synthesis of Coumarins Catalyzed by a Bifunctional Amine–Thiourea Catalyst

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Intravenous amiodarone is safe and seems to be effective in termination of paroxysmal supraventricular tachyarrhythmias

Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the amiodarone reduction in coronary heart (ARCH) trial

Intravenous amiodarone in treatment of recent-onset atrial fibrillation: Results of a randomized, controlled study

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases

Clinically relevant drug interactions with antiepileptic drugs

A New Equation to Estimate Glomerular Filtration Rate

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Antithrombotic Therapy for VTE Disease

Site I on human albumin: Differences in the binding of (R)- and (S)-warfarin

Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin

Myocarditis

Oral Anticoagulants

Pharmacological Importance of Stereochemical Resolution of Enantiomeric Drugs

Photoplethysmographic assessment of pulse wave reflection

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Clinical Pharmacokinetics of Molsidomine

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

High-Resolution and High-Throughput Protocols for Measuring Drug/Human Serum Albumin Interactions Using BIACORE

Enoximone

The Pharmacology and Management of the Vitamin K Antagonists

Atrial Arrhythmias after Cardiothoracic Surgery

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

Expert consensus document on arterial stiffness: methodological issues and clinical applications

High-dose nitrates in the immediate management of unstable angina: Optimal dosage, route of administration, and therapeutic goals

A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial

Myocarditis

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

Bifunctional Molecular Photoswitches Based on Overcrowded Alkenes for Dynamic Control of Catalytic Activity in Michael Addition Reactions

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Magnesium in Man: Implications for Health and Disease

Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

Interventions on Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Heart Surgery

Plasma disposition of vitamin K1 in relation to anticoagulant poisoning.

Stereoselective interaction between the R enantiomer of warfarin and cimetidine.

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Clinical significance of the sparteine/debrisoquine oxidation polymorphism

Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate.

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery

Lithium, membranes, and manic-depressive illness

Guidelines for the Primary Prevention of Stroke

Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

Clinical Pharmacokinetics of Oral Anticoagulants

Comparison of the electrophysiologic effects of intravenous and oral lorcainide in patients with recurrent ventricular tachycardia.

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

Warfarin STEREOCHEMICAL ASPECTS OF ITS METABOLISM AND THE INTERACTION WITH PHENYLBUTAZONE

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

Noninvasive Assessment of the Digital Volume Pulse

Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions

Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.

Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery

Sympatholytic Action of Intravenous Amiodarone in the Rat Heart

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Dynamic Inversion of Stereoselective Phosphate Binding to a Bisurea Receptor Controlled by Light and Heat

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Aortic Pulse-Wave Velocity and Its Relationship to Mortality in Diabetes and Glucose Intolerance

Interactions of Warfarin with Drugs and Food

Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Part 8: Adult Advanced Cardiovascular Life Support

National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification

Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.

Severe complications of antianginal drug therapy in a patient identified as a poor metabolizer of metoprolol, propafenone, diltiazem, and sparteine

Lack of Effect of Enoximone on the Pharmacokinetics of Digoxin in Patients with Congestive Heart Failure

Digital pulse plethysmography as a non-invasive method for predicting drug-induced changes in left ventricular preload

Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: Results of a prospective, placebo-controlled study

Elimination and distribution of phenylbutazone in rats during the course of adjuvant-induced arthritis.

Anticoagulant activity of the enantiomers of acenocoumarol.

Cyclic interconversion of vitamin K1 and vitamin K1 2,3‐epoxide in man.

Enhanced elimination of warfarin during treatment with cholestyramine.

Plasma protein binding of azapropazone in patients with kidney and liver disease.

Drug Interactions with Oral Anticoagulants

Interruption of the enterohepatic circulation of phenprocoumon by cholestyramine

Relationship between pharmacokinetics and pharmacodynamics of molsidomine and its metabolites in humans

Optical studies on the mechanism of the interaction of the enantiomers of the antiocagulant drugs phenprocoumon and warfarin with human serum albumin.

Isosorbide Dinitrate: Pharmacokinetics after Intravenous Administration

The enantiomers of phenprocoumon: Pharmacodynamic and pharmacokinetic studies

Differential effect of the enantiomers of phenprocoumon and warfarin on the vitamin K1-epoxide/vitamin K1 ratio in rat plasma

Pharmacokinetics of the enantiomers of acenocoumarol in man.

Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual, and percutaneous dosing in angina

Pharmacokinetics and Pharmacodynamics of the 5-HT2 Receptor Antagonist Ketanserin in Man

Drug interaction between propafenone and metoprolol.

Determination of Phenylbutazone in Plasma

Estimation of pharmacokinetic parameters of lithium from saliva and urine

Evidence for Impaired Hepatic Vitamin K1 Metabolism in Patients Treated with N-Methyl-Thiotetrazole Cephalosporins

Lorcainide; II. Plasma concentration‐effect relationship

Stereoselective drug distribution and anticoagulant potency of the enantiomers of phenprocoumon in rats

Age-dependent differences in the anticoagulant effect of phenprocoumon in patients after heart valve surgery